Vistusertib sulfate
| CAS No. | AZD2014 | Cat. No. | BCP25580 |
| Name | Vistusertib sulfate | ||
| Synonyms | AZD2014 sulfate; AZD-2014 sulfate; | ||
| Formula | C25H32N6O7S | M. Wt | 560.63 |
| Description | Vistusertib is an orally bioavailable inhibitor of the mammalian target of rapamycin (mTOR) with potential antineoplastic activity. Vistusertib inhibits the activity of mTOR, which may result in the induction of tumor cell apoptosis and a decrease in tumor cell proliferation. mTOR, a serine/threonine kinase that is upregulated in a variety of tumors, plays an important role downstream in the PI3K/Akt/mTOR signaling pathway. | ||
| Related Products | 1009298-59-2（Vistusertib） | ||
| Pathways | PI3K/Akt/mTOR | ||
| Targets | mTOR | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.